Ariceum Therapeutics receives FDA’s Orphan Drug Designation for targeted radionuclide cancer treatment

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has…

Continue ReadingAriceum Therapeutics receives FDA’s Orphan Drug Designation for targeted radionuclide cancer treatment

Targeted Thermal Therapy could transform management of common cause of high blood pressure

Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of a simple, minimally invasive Targeted Thermal Therapy (Triple T) that…

Continue ReadingTargeted Thermal Therapy could transform management of common cause of high blood pressure

Surge in violence in eastern Democratic Republic of the Congo leads to healthcare crisis

The recent surge in violence in the eastern Democratic Republic of the Congo has led to significant loss of life, trauma, displacement, and the destruction of critical health infrastructure, exacerbating…

Continue ReadingSurge in violence in eastern Democratic Republic of the Congo leads to healthcare crisis

Immune gene expression changes in myocardial infarction revealed through bioinformatics

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This study was aimed at exploring immune-related genes and their expression changes in myocardial infarction (MI) through comprehensive bioinformatics…

Continue ReadingImmune gene expression changes in myocardial infarction revealed through bioinformatics